XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Proceedings of the National Academy of Sciences

Influenza Channel
subscribe to Influenza newsletter

Latest Research : Infectious Diseases : Influenza

   DISCUSS   |   EMAIL   |   PRINT
Bird flu vaccine may be fruitless
Feb 14, 2006 - 7:37:00 PM, Reviewed by: Dr. Priya Saxena

"The antigenic diversity of viruses currently circulating in South East Asia and southern China challenges the wisdom of reliance on a single human vaccine for pandemic preparedness."

 
A vaccine the British government ordered as a defence against avian flu may not be effective, latest scientific findings suggest.

GlaxoSmithKline is one of the companies developing such a vaccine named as generic H5N1 and it plans to enter clinical trials in April. It expects to be in production by the end of the year, and is marketing it to the British government, among others.

The British government has ordered two to three million doses of this vaccine and is soon to announce which company among those who tendered has been awarded the contract.

Researchers led by Yi Guan, of Shantou University, China, who studied the avian flu in China and South East Asia said that the diversity of the viruses are such that the vaccine may be fruitless, reported Times Online.

Bird flu has killed at least 88 people in Asia and Turkey since 2003, according to the World Health Organization. Birds carrying the virus have also been detected in Italy, Greece and Nigeria.

The researchers indicated that the virus has been spreading in an uncontrolled fashion in China for the past decade, has crossed into Vietnam on three occasions and may be spread by "carrier" poultry that show no symptoms.

The team in their research published in Proceedings of the National Academy of Sciences concludes: "The antigenic diversity of viruses currently circulating in South East Asia and southern China challenges the wisdom of reliance on a single human vaccine for pandemic preparedness."

The British government's other defence against the pandemic flu is the antiviral drug Tamiflu, of which it has ordered 14.6 million courses. A spokeswoman for the department of health said that almost five million had been delivered so far, the report said.
 

- Indo-Asian News Service
 

 
Subscribe to Influenza Newsletter
E-mail Address:

 



Related Influenza News

Are influenza vaccines worth the effort?
Oseltamivir significantly reduces the risk of death from influenza
Prisons Unprepared for Flu Pandemic
University of Pittsburgh receives $1.3 million grant for developing a promising avian flu vaccine
Novel DNA-Based H5N1(Avian) influenza vaccine
Genetic differences between potential pandemic influenza strains outlined
Avian flu virus needs only minor adaptations to infect humans
Influenza-Associated Hospitalization in a Subtropical City
SRL Ranbaxy offers a quicker bird flu diagnostic test
Bird flu vaccine may be fruitless


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us